Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Bluejay Diagnostics (BJDX) Shares Outstanding (Diluted Average) (2021 - 2023)

Bluejay Diagnostics' Shares Outstanding (Diluted Average) history spans 3 years, with the latest figure at $2741.0 for Q4 2023.

  • On a quarterly basis, Shares Outstanding (Diluted Average) fell 99.73% to $2741.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $2741.0, a 99.73% decrease, with the full-year FY2023 number at $2741.0, down 99.73% from a year prior.
  • Shares Outstanding (Diluted Average) hit $2741.0 in Q4 2023 for Bluejay Diagnostics, down from $137871.0 in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for BJDX hit a ceiling of $20.1 million in Q1 2022 and a floor of $2741.0 in Q4 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $3.7 million across 3 years, with a median of $1.0 million in 2022.
  • The widest YoY moves for Shares Outstanding (Diluted Average): up 86.32% in 2023, down 99.73% in 2023.
  • Tracing BJDX's Shares Outstanding (Diluted Average) over 3 years: stood at $8.5 million in 2021, then plummeted by 88.17% to $1.0 million in 2022, then tumbled by 99.73% to $2741.0 in 2023.
  • Business Quant data shows Shares Outstanding (Diluted Average) for BJDX at $2741.0 in Q4 2023, $137871.0 in Q3 2023, and $127881.0 in Q2 2023.